Objective. The observation of higher rates of chronic widespread pain, the cardinal feature of fibromyalgia, in women has led to hypotheses about the role of sex hormonal factors in the aetiology of symptoms. There is little available evidence from epidemiological studies on their importance or role.
Chronic widespread pain is the cardinal symptom of fibromyalgia, one of the most common reasons for consultation at rheumatological clinics in western Europe and North America w1x. In the clinic, fibromyalgia is considerably more common in women than men, typically exhibiting a sex ratio of around 10 : 1. This excess cannot be explained completely by females with symptoms consulting more than males. Although the sex ratio is lower for studies of fibromyalgia and chronic widespread pain in the population, the excess amongst females is still evident. In Canada, a population telephone survey reported rates of chronic widespread pain among males and females of 4.7 and 9.0% respectively w2x, while a questionnaire population survey in the UK reported rates of 9.4 and 15.6% respectively w3x.
Despite the observation of higher prevalence rates in females, a feature shared with several other regional pain syndromes, the role of sex hormones in the occurrence and severity of symptoms is largely unknown. One retrospective study of a small group of 26 women with fibromyalgia found that they reported a worsening of symptoms during pregnancy and a further worsening of symptoms in the post-partum period w4x. A further small study of 16 patients with fibromyalgia reported that there were significant changes in pain reporting throughout the menstrual cycle, with pain scores highest in the peri-menstrual phase in comparison with the ovulatory phases w5x. A further two case-control studies of a specific regional pain syndrome, temporomandibular pain disorder, using automated pharmacy and health-care records suggested a relationship between the use of exogenous sex hormones and pain reporting w6x.
The aim of the present study was to determine whether endogenous or exogenous hormonal status was associated with reporting chronic widespread pain in an unselected population sample of females.
Methods

Study population
The sampling frame was the registered population of a general practice in Congleton, Cheshire. This is a market town in north-west England of mixed sociodemographic characteristics, similar to those of the whole county. The study sample, of 4000 subjects aged 18-65 yr, was selected by simple random sampling, and each received a questionnaire by post. Nonresponders were followed up successively with a postcard reminder, a further mailed questionnaire and a short version of the questionnaire. Those who had still not returned a completed questionnaire and had not declined to participate were thereafter offered the option of a telephone interview.
Information collected
The questionnaire asked about any pain experienced during the past month which had lasted at least 24 h. Those responding positively were asked to indicate the site of pain on body manikins, which allowed us to determine whether subjects satisfied the American College of Rheumatology (ACR) definition of chronic widespread pain w7x. In brief, this requires at least pain in the axial skeleton and contralateral quadrant body pain (e.g. pain in the top left and bottom right body quadrants) which has lasted more than 3 months. Additional items of the questionnaire enquired about menstrual history and symptoms, use of the oral contraceptive pill and hormone replacement therapy (HRT). A 12-item questionnaire (the premenstrual symptom questionnaire) was included, enquiring about 'how you usually feel in the week before a period' w8x. The items relate to gain in weight, tension, headache, stomach pains, anxietyuworry, backache, tiredness, feeling sick or vomiting, irritability, feeling swollen or bloated, depression, and tender breasts. Each is recorded as noneuslightumoderateusevere, corresponding to scores of 0-3 and providing a total score between 0 and 36. In addition, for the purpose of the present study, a modified nine-item scale, excluding the three pain items (backache, stomach-ache, headache), was constructed, providing a score between 0 and 27.
In order to determine the repeatability of some of the exposure information reported, a small group of 50 subjects stratified by pain status were randomly selected from amongst the participants and asked to complete an identical questionnaire 2 months after their original response. In addition, eight subjects voluntarily completed the questionnaire twice after they had inadvertently been sent a reminder questionnaire.
Analysis Analysis of the relationship between sociodemographic factors, reproductive factors and chronic widespread pain included all female subjects. Analysis of other hormonal factors and chronic widespread pain was conducted separately for pre-uperi-menopausal and post-menopausal women. Post-menopausal women were defined as those who reported that their periods had stopped completely. Analysis used Breslow's extension of the Cox regression model w9x and the relationships were expressed as relative risks (RR) with 95% confidence intervals (CI). This is a more meaningful effect measure for cross-sectional studies than the odds ratio w10x. Risk measures are shown crude and adjusted for age. Repeatability of categorical exposure reporting was assessed using k, a measure of agreement above that expected by chance. Values range from 0 (agreement at the level expected by chance) to 1 (perfect agreement) and values in the range 0.6-0.8 and >0.8 are considered as indicating good and very good agreement respectively w11x. The 95% CIs were also calculated for this measure of agreement. A reliability coefficient w12x was used to assess the reliability of continuous variables, such as the score derived from the premenstrual symptom questionnaire data.
Results
From 4000 persons selected randomly, a total of 2504 completed questionnaires were returned. Of the persons who did not return a questionnaire, 620 were assumed not to have received the questionnaire because they were no longer registered at that address on the electoral roll (n = 469), because notification had been received from the occupant or post office that the subject had moved (n = 132) or because we had been notified that the person was severely disabled or terminally ill (n = 13) or had died (n = 6). This resulted in an adjusted participation rate of 74%, which was higher in women (79%) than men (69%). For the present analysis, only female subjects who completed a full study questionnaire (n = 1245) with no missing information on pain status (n = 1178) were included. The prevalence of chronic widespread pain, using the ACR definition, amongst the female subjects was 11.2%.
Amongst pre-or peri-menopausal women (66% of the study participants), the risk of chronic widespread pain was unrelated either to the length of the menstrual cycle or to the usual reported length of a period. Risk was similar in current users and non-users of the oral contraceptive pill, and amongst users there was no relationship with duration of use ( Table 1 ). The reporting of chronic widespread pain did, however, show a relationship with the total score on the premenstrual symptom questionnaire. Relative to those with scores in the lowest tertile, those in the middle tertile had a risk (RR) of 1.29 (95% CI 0.66-2.53) and those in the highest tertile a risk of 2.02 (95% CI 1.10-3.70). When the modified premenstrual symptom scale score was considered (excluding items relating to regional pain sites), the relationship between scale score and chronic widespread pain was attenuated and no longer significant (RR 1.25, 95% CI 0.72-2.16).
Amongst post-menopausal women, reporting chronic widespread pain was not related to age at menopause (Table 2 ). There was an increased but non-significant risk associated with reporting current HRT.
Repeatability of exposure information
Forty-one women completed the questionnaire a second time approximately 2 months after completing the original questionnaire. The information on menstrual status showed perfect agreement (k = 1.0). Agreement for all other factors wever had painful periods, k = 0.6, 95% CI 0.4-0.9; use of oral contraceptive, k = 0.7, 95% CI 0.4-1.0; HRT use, k = 0.9, 95% CI 0.6-1.0) was within the range which is considered to represent good or very good agreement. The reliability coefficient for the premenstrual symptom questionnaire was 0.91, which, given a maximum possible coefficient of 1.0, is considered to be high.
Discussion
This study has not provided any strong evidence that sex hormonal factors are related to chronic widespread pain. Pain was not related to any of the hormonalu menopausal factors examined in pre-uperi-or postmenopausal women. Amongst post-menopausal women, risk increased modestly (and not significantly) with duration of hormone replacement therapy, although this may have reflected the prescription of HRT because of menopausal symptoms.
There are few other epidemiological studies of musculoskeletal pain and sex hormones with which to compare these results. This may be because it has not been studied previously or that studies, failing to find an association, have not been published (i.e. publication bias). Two studies of healthy subjects reported no correlation between the hormonal phase of the menstrual cycle and pain threshold measurements or the elicitation of tender points w13, 14x, while in a study of 40 pregnant patients with fibromyalgia, although severity changed during pregnancy, severity was not related to hormonal changes associated with abortion, the use of hormonal contraceptives or breast-feeding w4x.
If the difference in prevalence of chronic widespread pain between men and women is not explained by sex hormones, what other explanations could there be for the difference? There is little evidence that genetic factors are important. A study comparing monozygotic with dizygotic twins showed similar rates of concordance for pain threshold w15x. A possible explanation for the difference in prevalence rate is that women have a lower threshold for reporting these symptoms. This may be due to differences in pain processing mechanisms, differences in coping strategies or social factors. For example, in the case of social factors, it may be considered more acceptable for women to report such symptoms than men. An alternative hypothesis is that women are more commonly exposed to risk factors for the development of chronic widespread pain. There is some evidence for all these hypotheses from studies of regional and chronic widespread pain w16-18x, and future studies may usefully clarify the role of each.
Conclusion
This study, the first to examine the relationship between chronic widespread pain and sex hormonal factors, both endogenous and exogenous, in a large unselected population, failed to demonstrate consistent associations. It seems unlikely that such factors can account for the gender differences observed.
